GHDX
Genomic Health, Inc.
GHDX
GHDX
Delisted
GHDX was delisted on the 7th of November, 2019.
215 hedge funds and large institutions have $2.06B invested in Genomic Health, Inc. in 2019 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 95 increasing their positions, 71 reducing their positions, and 62 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
19% less funds holding
Funds holding: 267 → 215 (-52)
76% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 62
Holders
215
Holding in Top 10
1
Calls
$2.02M
Puts
$1.77M
Top Buyers
| 1 | +$30.4M | |
| 2 | +$27.9M | |
| 3 | +$25.3M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
+$25.3M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$18.5M |
Top Sellers
| 1 | -$54.6M | |
| 2 | -$28.4M | |
| 3 | -$18.7M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$13.3M |
| 5 |
Robeco Institutional Asset Management
Rotterdam,
Netherlands
|
-$10.9M |